Comparison of different miR-21 inhibitor chemistries in a cardiac disease model

被引:96
作者
Thum, Thomas [1 ,2 ]
Chau, Nelson [3 ]
Bhat, Balkrishen [3 ]
Gupta, Shashi Kumar [1 ]
Linsley, Peter S. [3 ]
Bauersachs, Johann [2 ]
Engelhardt, Stefan [4 ]
机构
[1] Hannover Med Sch, IFB Tx, Inst Mol & Translat Therapeut Strategies, D-30625 Hannover, Germany
[2] Hannover Med Sch, Dept Cardiol & Angiol, D-30625 Hannover, Germany
[3] Regulus Therapeut, San Diego, CA USA
[4] Tech Univ Munich, Inst Pharmacol & Toxicol, D-8000 Munich, Germany
关键词
D O I
10.1172/JCI45938
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:461 / 462
页数:2
相关论文
共 4 条
[1]  
Levin AA., 2007, Antisense Drug Technology: Principles, Strategies, and Applications, P183, DOI DOI 10.1201/9780849387951.CH7
[2]   miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis [J].
Liu, Gang ;
Friggeri, Arnaud ;
Yang, Yanping ;
Milosevic, Jadranka ;
Ding, Qiang ;
Thannickal, Victor J. ;
Kaminski, Naftali ;
Abraham, Edward .
JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 207 (08) :1589-1597
[3]   Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice [J].
Patrick, David M. ;
Montgomery, Rusty L. ;
Qi, Xiaoxia ;
Obad, Susanna ;
Kauppinen, Sakari ;
Hill, Joseph A. ;
van Rooij, Eva ;
Olson, Eric N. .
JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (11) :3912-3916
[4]   MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts [J].
Thum, Thomas ;
Gross, Carina ;
Fiedler, Jan ;
Fischer, Thomas ;
Kissler, Stephan ;
Bussen, Markus ;
Galuppo, Paolo ;
Just, Steffen ;
Rottbauer, Wolfgang ;
Frantz, Stefan ;
Castoldi, Mirco ;
Soutschek, Jurgen ;
Koteliansky, Victor ;
Rosenwald, Andreas ;
Basson, M. Albert ;
Licht, Jonathan D. ;
Pena, John T. R. ;
Rouhanifard, Sara H. ;
Muckenthaler, Martina U. ;
Tuschl, Thomas ;
Martin, Gail R. ;
Bauersachs, Johann ;
Engelhardt, Stefan .
NATURE, 2008, 456 (7224) :980-U83